Search Technologies
Filters
Fields
All (71)
Agriculture (10)
Analytical Instrumentation (7)
Clean Technology (18)
Diagnostic Assays (1)
Education & Training (8)
Engineering (5)
Engines & Power Electronics (5)
Food & Supplements (7)
Information Technology (2)
Materials & Chemicals (22)
Medical Devices (6)
Medical Imaging (1)
Micro & Nanotech (5)
Miscellaneous (7)
Pharmaceuticals & Vitamin D (8)
Research Tools (2)
UW Institutions
13 WiSys Technologies in "Pharmaceuticals & Vitamin D" or "Micro & Nanotech"
Photochemical Preparation of Fluorinated Aryl Ethers for Agrochemicals and Pharmaceuticals
WiSys is seeking a strategic partner in the agrochemical industry who can provide a route to market for the commercialization, scale-up, and use of this novel method for synthesis of aryl fluorinated ethers for pharmaceuticals and agrochemicals.
Non-Linear Stimuli-Responsive Block Copolymers as Dispersants and Rheological Modifiers in Architectural Coatings
WiSys is currently seeking strategic partners in the coatings industry that are interested in co-development opportunities that would ultimately provide a route to market for commercialization of these novel copolymers.
Linear Stimuli-Responsive Block Copolymers as Dispersants and Rheological Modifiers in Architectural Coatings
WiSys is currently seeking strategic partners in the coatings industry that are interested in co-development opportunities that would ultimately provide a route to market for commercialization of these novel copolymers.
Carbon Nanotube Vacuum Field Emission Transistor Design for Large-Scale Manufacturing
WiSys is currently seeking strategic partners in the next generation transistor industry that are interested in further optimizing the design for large-scale manufacturing, ultimately providing a path to market for its commercialization.
Skin Whitening Agent(s)
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.
Benzodiazepine Derivatives with Reduced Side Effects
The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.